8-K
Current Report
HALOZYME THERAPEUTICS, INC. Filed Acc 0000936392-07-000441
Executive or director change · Bylaws or fiscal year change
- Item 5.02 Departure or appointment of directors or officers
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading a30445e8vk.htm…